113 related articles for article (PubMed ID: 34431528)
1. Pharmacokinetic Profiles of Metamizole Metabolites after Intramuscular and Intravenous Administration in Healthy Arabian Horses.
Yılmaz İ; Maraş Z; Uğur Y; Erkan Özgür M; Durmaz M; İbrahim Ulusoy H; Erdoğan S
J Vet Pharmacol Ther; 2021 Nov; 44(6):927-936. PubMed ID: 34431528
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profiles of the active metamizole metabolites in healthy horses.
Giorgi M; Aupanun S; Lee HK; Poapolathep A; Rychshanova R; Vullo C; Faillace V; Laus F
J Vet Pharmacol Ther; 2017 Apr; 40(2):165-171. PubMed ID: 27477925
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs.
Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Owen H; Poapolathep A; Kim TW; De Vito V
J Vet Pharmacol Ther; 2018 Jun; 41(3):428-436. PubMed ID: 29352476
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets.
Burmańczuk A; Kowalski C; Giorgi M; Owen H; Grabowski T
J Vet Pharmacol Ther; 2016 Dec; 39(6):616-620. PubMed ID: 27199202
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus).
de Macêdo LB; Mouta AN; Araújo-Silva G; Urizar JTP; de Paula VV
J Vet Pharmacol Ther; 2021 Sep; 44(5):842-849. PubMed ID: 34268764
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profiles of metamizole (dipyrone) active metabolites in goats and its residues in milk.
Kim TW; Łebkowska-Wieruszewska B; Sitovs A; Poapolathep A; Owen H; Lisowski A; Abilova Z; Giorgi M
J Vet Pharmacol Ther; 2018 Oct; 41(5):699-705. PubMed ID: 29943417
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profiles of the two major active metabolites of metamizole (dipyrone) in cats following three different routes of administration.
Lebkowska-Wieruszewska B; Kim TW; Chea B; Owen H; Poapolathep A; Giorgi M
J Vet Pharmacol Ther; 2018 Apr; 41(2):334-339. PubMed ID: 29164623
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profiles of the two major active metabolites of metamizole, 4-methylaminoantipyrine (MAA) and 4-aminoantipyrine (AA), after intravenous injection in cats.
de Paula VV; Araújo-Silva G; Fernandes NS; Mouta AN; Nunes TL; de Paiva ALC; de Macêdo LB; Arcoverde KN; Urizar JTP
Res Vet Sci; 2023 Feb; 155():156-160. PubMed ID: 36701839
[TBL] [Abstract][Full Text] [Related]
9. Comparative bioavailability of two oral metamizole formulations. Influence of the acetylation phenotype.
Bacracheva N; Drenska A; Gorantcheva J; Tyutyulkova N; Vlahov V
Arzneimittelforschung; 1995 Mar; 45(3):282-5. PubMed ID: 7741785
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of metamizole (dipyrone) as an add-on in calves undergoing umbilical surgery.
Fux D; Metzner M; Brandl J; Feist M; Behrendt-Wippermann M; von Thaden A; Baumgartner C
PLoS One; 2022; 17(3):e0265305. PubMed ID: 35290991
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutic monitoring of dipyrone in northeastern Brazilian donkeys (Equus asinus).
Arcoverde KN; Alves LSA; Cavalcante JM; Maranhão ACPM; Jurema AP; Araújo-Silva G; Urizar JTP; de Paula VV
Res Vet Sci; 2023 Nov; 164():105034. PubMed ID: 37820460
[TBL] [Abstract][Full Text] [Related]
12. 4-Methylamino antipyrine determination in human plasma by high-performance liquid chromatography tandem mass spectrometry.
Nikitina A; Gildeeva G; Grigoriev A; Sidorova A
Biomed Chromatogr; 2020 Oct; 34(10):e4913. PubMed ID: 32510593
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of dipyrone and its metabolites.
Levy M; Zylber-Katz E; Rosenkranz B
Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules.
Artaza MA; Puerta JL; Ortiz R; Laporte JR
Int J Clin Pharmacol Ther; 2002 Jul; 40(7):322-6. PubMed ID: 12139210
[TBL] [Abstract][Full Text] [Related]
15. Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro.
Bacracheva N; Kamali F
Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):299-301. PubMed ID: 8830197
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of dipyrone in horses: A multi-dose, dose escalation study.
O'Banion MP; Sundman E; Edmonds M; Davis J
J Vet Pharmacol Ther; 2021 Nov; 44(6):919-926. PubMed ID: 34228836
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study.
Anliker-Ort M; Rodieux F; Ziesenitz VC; Atkinson A; Bielicki JA; Erb TO; Gürtler N; Holland-Cunz S; Duthaler U; Rudin D; Haschke M; van den Anker J; Pfister M; Gotta V
J Clin Pharmacol; 2024 Jul; 64(7):810-819. PubMed ID: 38497339
[TBL] [Abstract][Full Text] [Related]
18. Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics.
Caraco Y; Zylber-Katz E; Granit L; Levy M
Arzneimittelforschung; 1993 Nov; 43(11):1204-8. PubMed ID: 8292065
[TBL] [Abstract][Full Text] [Related]
19. Effect of cimetidine on the pharmacokinetics of the metabolites of metamizol.
Bacracheva N; Tyutyulkova N; Drenska A; Gorantcheva J; Schinzel S; Scholl T; Stoinov A; Tchakarski I; Tentcheva J; Vlahov V
Int J Clin Pharmacol Ther; 1997 Jul; 35(7):275-81. PubMed ID: 9247840
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.
Vlahov V; Badian M; Verho M; Bacracheva N
Eur J Clin Pharmacol; 1990; 38(1):61-5. PubMed ID: 2328750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
